Serum IL-15 in Patients With Early Systemic Sclerosis: A Potential Novel Marker of Lung Disease

Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar2284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Predictors of Progression in Systemic Sclerosis Patients With Interstitial Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2020English

Circulating Angiostatin Serum Level in Patients With Systemic Sclerosis

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2017English

Serum Levels of Leptin Receptor in Patients With Systemic Sclerosis

Intractable and Rare Diseases Research
Medicine
2013English

Predictors of Exercise-Induced Oxygen Desaturation in Systemic Sclerosis Patients With Interstitial Lung Disease

Respiratory Care
MedicinePulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2013English

Capillaroscopy Changes Are Associated With Disease Progression in Patients With Early Systemic Sclerosis: A Prospective Study

International Journal of Rheumatic Diseases
Rheumatology
2019English

Clinical Association of Serum Interleukin-17 Levels in Systemic Sclerosis: Is Systemic Sclerosis a Th17 Disease?

Journal of Dermatological Science
DermatologyBiochemistryMolecular Biology
2008English

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Outcomes in Systemic Sclerosis–Related Lung Disease After Lung Transplantation

Transplantation
Transplantation
2013English

Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy